Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies

U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

(2013) Marie R. Griffin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy

(2013) Sara Boccalini et al.   Human Vaccines & Immunotherapeutics

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England

(2012) Albert Jan van Hoek et al.   JOURNAL OF INFECTION

Why it is still important that countries know the burden of pneumococcal disease

(2011) Rosa Prato et al.   Human vaccines & immunotherapeutics

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States

(2011) L. Simonsen et al.   mBio

Burden of Community-Acquired Pneumonia in North American Adults

(2010) Thomas M. File et al.   POSTGRADUATE MEDICINE

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy

(2008) Paolo Giorgi-Rossi et al.   HEALTH POLICY